FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/07/044131 [Registered on: 19/07/2022] Trial Registered Prospectively
Last Modified On: 14/07/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Role of Kadambmasha Anuvasana Basti and Badrodak Asthapna Basti in normal delivery 
Scientific Title of Study   A Clinical study to evaluate the Efficacy of Kadambmasha Anuvasana Basti and Badrodak Asthapna Basti in Sukh and Nirupdrava Prasava 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Soni Kapil 
Designation  Reader, Department of Prasuti Tantra evum Stree Roga 
Affiliation  RGGPG Ayurvedic College and Hospital, Paprola 
Address  Room no. 203, Department of Prasuti Tantra evum Stree Roga, RGGPG Ayurvedic College and Hospital, Paprola, Distt. Kangra

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418499799  
Fax    
Email  skbhardwaj73@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Soni Kapil 
Designation  Reader, Department of Prasuti Tantra evum Stree Roga 
Affiliation  RGGPG Ayurvedic College and Hospital, Paprola 
Address  Room no. 203, Department of Prasuti Tantra evum Stree Roga, RGGPG Ayurvedic College and Hospital, Paprola, Distt. Kangra

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418499799  
Fax    
Email  skbhardwaj73@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nisha Kumari 
Designation  PG Scholar 
Affiliation  RGGPG Ayurvedic College and Hospital, Paprola 
Address  Room no. 804, Department of Prasuti Tantra evum Street Roga, RGGPG Ayurvedic College and Hospital, Paprola, Distt. Kangra

Kangra
HIMACHAL PRADESH
176115
India 
Phone  8265031734  
Fax    
Email  nisha27bhatia@gmail.com  
 
Source of Monetary or Material Support  
Charak Pharmacy, RGGPG Ayurvedic College and Hospital 
ISM Jogindernagar 
 
Primary Sponsor  
Name  Principal RGGPG Ayurvedic College and Hospital Paprola 
Address  Principal Room, Admin Block, RGGPG Ayurvedic College and Hospital, Paprola, Distt. Kangra HP 176115 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
HOD Department of Prasuti Tantra Evum Stree Roga  RGGPG Ayurvedic College and Hospital, Paprola, Distt. Kangra H. P.  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Soni Kapil  RGGPG Ayurvedic College and Hospital, Paprola  OPD and IPD of Department of Prasuti Tantra evum Stree Roga, RGGPG Ayurvedic College and Hospital, Paprola
Kangra
HIMACHAL PRADESH 
9418499799

skbhardwaj73@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee (Human), RGGPG Ayurvedic College and Hospital, Paprola  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:O80||Encounter for full-term uncomplicated delivery. Ayurveda Condition: GARBAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Kadambmasha Taila, Reference: Bhel Samhita Sharir Sthana 8/7, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 3 Weeks, anupAna/sahapAna: No, Additional Information: Kadambmasha Taila 60ml per rectal twice weekly for 3 weeks and at the onset of labour after Badrodak Asthapna Basti
(2) Medicine Name: Badrodak Kwath, Reference: Sushruta Samhita Sharir Sthana 10/4, Route: Rectal, Dosage Form: Kwatha/ Kashaya, Dose: 960(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 1 Days, anupAna/sahapAna: No, Additional Information: Badrodak Kwath 960ml per rectal at the onset of labour
2Comparator Arm (Non Ayurveda)-Standard ANC ProtocolStandard ANC Protocol
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1. Cases having haematological/routine ANC investigations within normal limits.
2. Patients having adequate pelvis, borderline pelvis and cephalic presentation.  
 
ExclusionCriteria 
Details  1. Cephalopelvic disproportion.
2. Patient not willing for trial.
3. Patients having mal presentation.
4. Antepartum haemorrhage.
5. Patients having Hb less than 9gm%.
6. Patients having any gynaecological conditions or systemic disease.
 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. Onset of spontaneous labour and normal progress of labour.
2. Delivery of fetus with minimal aids.  
32 weeks to onset of Labour (5-7 weeks).
1. Patient will be observed after intervention whether the pregnant woman has sukha and nirupdrava prasava or not and
2. whether onset of labour is spontaneous or induced 
 
Secondary Outcome  
Outcome  TimePoints 
Uneventful complition of labour without interfering maternal and fetal health  Mother and Infant will be observed regularly for 14 days after delivery for any complication 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   14/08/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Research Report will be soon published after the completion of trial. 100 patients fulfilling the inclusion and exclusion criteria will be randomly selected from the OPD and IPD of Department of Prasuti Tantra evum Stree Roga, RGGPG Ayurvedic College and Hospital, Paprola. Patients will be divided randomly into 2 groups; Group I and Group II each with 50 patients. Group I will be given Kadambmasa Anuvasana Basti (Matra Basti) twice weekly for consecutive 3 weeks and Badrodak Asthapna Basti followed by Anuvasna Basti at the onset of labour while Group II includes the pregnant women under observation by following standard protocol used for ANC and normal labour (non-interventional). Result will be assessed on the basis of subjective and objective assessment criteria.
 
Close